Deutsch SI - Search Results

1

Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.

Amatniek J, Canuso CM, Deutsch SI, Henderson DC, Mao L, Mikesell C, Rodriguez S, Sheehan J, Alphs L. Amatniek J, et al. Among authors: deutsch si. Clin Schizophr Relat Psychoses. 2014 Apr;8(1):8-20. doi: 10.3371/CSRP.AMCA.021513. Clin Schizophr Relat Psychoses. 2014. PMID: 23428785

2

Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.

Deutsch SI, Schwartz BL, Schooler NR, Brown CH, Rosse RB, Rosse SM. Deutsch SI, et al. Schizophr Res. 2013 Aug;148(1-3):138-44. doi: 10.1016/j.schres.2013.05.023. Epub 2013 Jun 13. Schizophr Res. 2013. PMID: 23768813 Free PMC article. Clinical Trial.

3

Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.

Deutsch SI, Rosse RB, Kendrick KA, Fay-McCarthy M, Collins JP Jr, Wyatt RJ. Deutsch SI, et al. Clin Neuropharmacol. 1993 Dec;16(6):518-24. Clin Neuropharmacol. 1993. PMID: 9377587 Clinical Trial.

4

An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy.

Rosse RB, Kendrick K, Fay-McCarthy M, Prell GD, Rosenberg P, Tsui LC, Wyatt RJ, Deutsch SI. Rosse RB, et al. Among authors: deutsch si. Clin Neuropharmacol. 1996 Aug;19(4):341-8. doi: 10.1097/00002826-199619040-00007. Clin Neuropharmacol. 1996. PMID: 8828997 Clinical Trial.

5

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.

Rosse RB, Fay-McCarthy M, Kendrick K, Davis RE, Deutsch SI. Rosse RB, et al. Among authors: deutsch si. Clin Neuropharmacol. 1996 Oct;19(5):444-50. doi: 10.1097/00002826-199619050-00008. Clin Neuropharmacol. 1996. PMID: 8889288 Clinical Trial.

6

Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory study.

Rosenberg PB, Rosse RB, Schwartz BL, Deutsch SI. Rosenberg PB, et al. Among authors: deutsch si. Clin Neuropharmacol. 2000 Jul-Aug;23(4):222-5. doi: 10.1097/00002826-200007000-00011. Clin Neuropharmacol. 2000. PMID: 11020129 Clinical Trial.

7

Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia.

Rosse RB, Schwartz BL, Zlotolow S, Banay-Schwartz M, Trinidad AC, Peace TD, Deutsch SI. Rosse RB, et al. Among authors: deutsch si. Clin Neuropharmacol. 1992 Apr;15(2):129-41. doi: 10.1097/00002826-199204000-00007. Clin Neuropharmacol. 1992. PMID: 1350512 Clinical Trial.

8

L-tyrosine pharmacotherapy of schizophrenia: preliminary data.

Deutsch SI, Rosse RB, Schwartz BL, Banay-Schwartz M, McCarthy MF, Johri SK. Deutsch SI, et al. Clin Neuropharmacol. 1994 Feb;17(1):53-62. doi: 10.1097/00002826-199402000-00006. Clin Neuropharmacol. 1994. PMID: 8149360 Clinical Trial.

9

Methylene blue adjuvant therapy of schizophrenia.

Deutsch SI, Rosse RB, Schwartz BL, Fay-McCarthy M, Rosenberg PB, Fearing K. Deutsch SI, et al. Clin Neuropharmacol. 1997 Aug;20(4):357-63. doi: 10.1097/00002826-199708000-00008. Clin Neuropharmacol. 1997. PMID: 9260734 Clinical Trial.

10

Correlation between antisaccade and Wisconsin Card Sorting Test performance in schizophrenia.

Rosse RB, Schwartz BL, Kim SY, Deutsch SI. Rosse RB, et al. Among authors: deutsch si. Am J Psychiatry. 1993 Feb;150(2):333-5. doi: 10.1176/ajp.150.2.333. Am J Psychiatry. 1993. PMID: 8422090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page